Skip to content

The Fruhwirth Lab

  • Home
  • Our Research – Imaging Therapies and Cancer
  • Our Team
  • Gallery
  • Contact us…
24th Mar 2024 Admin

First author paper for Rico

A great team effort in the arena of drug delivery, led by our PhD student Rico, and published early Jan 2024 in the European Journal of Pharmaceutics and Biopharmaceutics. Congratulations Rico!

https://doi.org/10.1016/j.ejpb.2024.114177

Share this:

  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on Reddit (Opens in new window) Reddit
  • Tweet
  • Click to print (Opens in new window) Print
Like Loading...
Unknown's avatar

Published by Admin

View all posts by Admin

Post navigation

Dynamic whole-body in vivo microRNA imaging enabled…
A Chapter Closed – Rico received his PhD Award!

Where we work...

Guy's Cancer Centre,
Innovation Hub 9th floor,
Great Maze Pond,
SE1 9RT London,
United Kingdom
  • SE1 9RT, Great Maze Pond, London, England

RSS Latest Publications

  • Development and characterisation of improved unifocal primary mouse lung cancer models with metastatic potential
  • Stromal lipid species dictate melanoma metastasis and tropism
  • Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis
  • An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities
  • Gene editing enables non-invasive in vivo PET imaging of human induced pluripotent stem cell-derived liver bud organoids
  • Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance
  • In Vitro and Preclinical Systematic Dose-Effect Studies of Auger Electron- and β Particle-Emitting Radionuclides and External Beam Radiation for Cancer Treatment
  • Multi-scale in vivo imaging of tumour development using a germline conditional triple-reporter system
  • Drug-resistant EGFR mutations promote lung cancer by stabilizing interfaces in ligand-free kinase-active EGFR oligomers
  • Co-delivery of PD-L1- and EGFR-targeting siRNAs by synthetic PEG12-KL4 peptide to the lungs as potential strategy against non-small cell lung cancer

Translate

Create a website or blog at WordPress.com
  • Subscribe Subscribed
    • The Fruhwirth Lab
    • Already have a WordPress.com account? Log in now.
    • The Fruhwirth Lab
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d